DK1721992T3 - Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme - Google Patents

Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme

Info

Publication number
DK1721992T3
DK1721992T3 DK06007989T DK06007989T DK1721992T3 DK 1721992 T3 DK1721992 T3 DK 1721992T3 DK 06007989 T DK06007989 T DK 06007989T DK 06007989 T DK06007989 T DK 06007989T DK 1721992 T3 DK1721992 T3 DK 1721992T3
Authority
DK
Denmark
Prior art keywords
nucleic acids
detecting
methods
proliferative disease
cellular proliferative
Prior art date
Application number
DK06007989T
Other languages
Danish (da)
English (en)
Inventor
Catherine Lofton-Day
Andrew Sledziewski
Ralf Lesche
Matthias Schuster
Juergen Distler
Reimo Tetzner
Thomas Hildmann
Fabian Model
Xiaoling Song
Original Assignee
Epigenomics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36746665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1721992(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Epigenomics Ag filed Critical Epigenomics Ag
Application granted granted Critical
Publication of DK1721992T3 publication Critical patent/DK1721992T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06007989T 2005-04-15 2006-04-18 Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme DK1721992T3 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US67224205P 2005-04-15 2005-04-15
US67699705P 2005-05-02 2005-05-02
US69752105P 2005-07-08 2005-07-08
US70486005P 2005-08-01 2005-08-01
US70931805P 2005-08-17 2005-08-17
US72360205P 2005-10-04 2005-10-04
US78740206P 2006-03-30 2006-03-30

Publications (1)

Publication Number Publication Date
DK1721992T3 true DK1721992T3 (da) 2009-02-02

Family

ID=36746665

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06007989T DK1721992T3 (da) 2005-04-15 2006-04-18 Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme

Country Status (20)

Country Link
US (8) US7951563B2 (fr)
EP (4) EP1877577A2 (fr)
JP (2) JP5341506B2 (fr)
KR (3) KR101708544B1 (fr)
CN (3) CN107663538B (fr)
AT (1) ATE410524T1 (fr)
AU (1) AU2006236620B2 (fr)
BR (1) BRPI0607508B8 (fr)
CA (1) CA2606296C (fr)
DE (1) DE602006003012D1 (fr)
DK (1) DK1721992T3 (fr)
EA (1) EA013634B1 (fr)
ES (2) ES2533767T3 (fr)
IL (1) IL186556A (fr)
MX (1) MX2007012782A (fr)
PL (1) PL1721992T3 (fr)
PT (1) PT1721992E (fr)
SG (1) SG183708A1 (fr)
SI (1) SI1721992T1 (fr)
WO (1) WO2006113466A2 (fr)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1863927B (zh) 2003-09-04 2010-08-11 人类遗传标记控股有限公司 核酸检测分析
US7833942B2 (en) * 2004-12-03 2010-11-16 Human Genetic Signatures Pty. Ltd. Methods for simplifying microbial nucleic acids by chemical modification of cytosines
EP1877577A2 (fr) 2005-04-15 2008-01-16 Epigenomics Inc. Méhodes et acides nucléiques utilisés dans des analyses de troubles prolifératifs cellulaires
JP2008541705A (ja) * 2005-05-26 2008-11-27 ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド 非標準塩基を含むプライマーを使用する等温鎖置換増幅
WO2007030882A1 (fr) 2005-09-14 2007-03-22 Human Genetic Signatures Pty Ltd Essai pour un état de santé
EP2013360A2 (fr) * 2006-04-17 2009-01-14 Epigenomics AG Procédés et acides nucléiques pour détecter des troubles de prolifération de cellules colorectales
US20080050738A1 (en) * 2006-05-31 2008-02-28 Human Genetic Signatures Pty Ltd. Detection of target nucleic acid
US20100143902A1 (en) * 2006-07-21 2010-06-10 Epigenomics Ag Methods and nucleic acids for analyses of cellular proliferative disorders
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
US7662566B2 (en) * 2006-11-22 2010-02-16 Myriad Genetics, Inc. Gene copy number profiling
US20080221056A1 (en) * 2007-02-12 2008-09-11 Johns Hopkins University Early Detection and Prognosis of Colon Cancers
US20100092972A1 (en) * 2007-03-16 2010-04-15 Human Genetic Signatures Pty Ltd. Assay for gene expression
WO2008122447A2 (fr) * 2007-04-10 2008-10-16 Epigenomics Ag Dosage de méthylation d'adn permettant de réaliser le diagnostic ou le pronostic d'états pathologiques
SI3101141T1 (sl) 2007-06-08 2020-03-31 Epigenomics Ag Postopek za metilacijsko analizo
FR2919061B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
CN101918595A (zh) 2007-11-27 2010-12-15 人类遗传标记控股有限公司 用于扩增和复制亚硫酸氢盐修饰的核酸的酶
AU2008334901A1 (en) * 2007-12-11 2009-06-18 Epigenomics Ag Methods and nucleic acids for analyses of lung carcinoma
US20110003700A1 (en) * 2007-12-20 2011-01-06 Human Genetic Signatures Pty Ltd. Elimination of contaminants associated with nucleic acid amplification
TW200927925A (en) * 2007-12-27 2009-07-01 Agriculture And Food Agency Council Of Agriculture Specific Promoter Region Expresses in Actively Dividing Young Tissues and the Aging Tissues in Plants and its Application
WO2009115920A1 (fr) * 2008-03-18 2009-09-24 Epigenomics Ag Procédé d’optimisation et de validation d’un essai permettant de déterminer la présence ou l’absence d’une condition médicale
EP2337868A4 (fr) * 2008-10-09 2012-03-28 British Columbia Cancer Agency Détection de tumeurs de la granulosa
ES2534200T3 (es) * 2009-08-03 2015-04-20 Epigenomics Ag Métodos para la preservación de la complejidad de la secuencia del ADN genómico
TWI434937B (zh) * 2009-10-28 2014-04-21 Univ Nat Chunghsing 具有廣泛性抗木瓜輪點病毒特性的基因轉殖木瓜品系１８－２－４之核酸分子及其檢測方法及應用
GB201004147D0 (en) * 2010-03-12 2010-04-28 Dna Electronics Ltd Method and apparatus for sensing methylation
KR101747191B1 (ko) 2011-01-14 2017-06-14 에스케이하이닉스 주식회사 반도체 장치
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
WO2012167145A2 (fr) * 2011-06-01 2012-12-06 University Of Southern California Analyse à l'échelle du génome d'une méthylation aberrante de l'adn dans le cancer colorectal
FI20115709A0 (fi) * 2011-07-01 2011-07-01 Helsingin Yliopisto Menetelmä perinnöllisten syöpien diagnosointiin
PH12014500063A1 (en) * 2011-07-08 2014-02-17 Epigenomics Ag Methods and nucleic acids for determining the prognosis of a cancer subject
BR112014005253B1 (pt) 2011-09-07 2019-11-05 Human Genetic Signatures Pty Ltd método de detecção molecular
US9546403B1 (en) 2011-12-14 2017-01-17 University Of Utah Research Foundation Substrate for methylated DNA testing
WO2013142545A1 (fr) * 2012-03-20 2013-09-26 Exact Sciences Corporation Panel de marqueurs pour la détection du cancer
CA2883671A1 (fr) * 2012-08-31 2014-03-06 National Defense Medical Center Methode de depistage du cancer
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
KR101476769B1 (ko) * 2013-01-02 2014-12-26 대구대학교 산학협력단 leucine-richα-2 glyprotein를 함유하는 대장암 진행예측용 바이오마커 조성물 및 이를 포함하는 대장암 진단용 바이오키트
JP6369857B2 (ja) * 2013-05-29 2018-08-08 シスメックス株式会社 肝細胞癌に関する情報の取得方法、ならびに肝細胞癌に関する情報を取得するためのマーカーおよびキット
KR101527283B1 (ko) * 2013-08-13 2015-06-10 서울대학교산학협력단 당단백질의 탈당화 검출을 통한 암 마커 스크리닝 방법 및 간세포암 마커
KR101438519B1 (ko) * 2014-07-01 2014-09-17 대구대학교 산학협력단 complement factor B를 함유하는 대장암 진행예측용 바이오마커 조성물 및 이를 포함하는 대장암 진단용 바이오키트
US10342238B2 (en) 2014-07-03 2019-07-09 Aktiebolaget Electrolux Household appliance mixing arrangement
US10258050B2 (en) 2014-07-03 2019-04-16 Aktiebolaget Electrolux Household appliance mixing arragement
EP3543356B1 (fr) 2014-07-18 2021-06-30 The Chinese University of Hong Kong Analyse de motifs de méthylation de tissus dans un mélange d'adn
CN104745575B (zh) 2014-08-08 2019-03-12 博诚研究中心 用于检测细胞增殖性异常或疾病程度分级的基因组合物及其用途
HRP20190787T1 (hr) * 2014-12-19 2019-08-09 Epigenomics Ag Metoda otkrivanja cpg (na mjestima citozin-fosfat-guanin)metilacije i dijagnosticiranje karcinoma
US20180143198A1 (en) * 2014-12-26 2018-05-24 Peking University Method for detecting differentially methylated cpg islands associated with abnormal state of human body
CN115181802A (zh) * 2015-04-23 2022-10-14 博尔诚（北京）科技有限公司 一种检测Septin9基因甲基化的试剂盒及其应用
CN104830855A (zh) * 2015-05-21 2015-08-12 基因科技（上海）有限公司 一种检测sept9基因甲基化的探针及其应用
US12300356B2 (en) * 2016-05-04 2025-05-13 Queen's University At Kingston Cell-free detection of methylated tumour DNA
RU2630669C1 (ru) * 2016-07-21 2017-09-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ определения метилирования сайтов PuCGPy регуляторных областей генов-онкомаркеров колоректального рака методом GLAD-ПЦР-анализа и набор олигонуклеотидных праймеров и флуоресцентно-меченых зондов для осуществления указанного способа
CN116445593A (zh) 2016-08-10 2023-07-18 格里尔公司 测定一生物样品的一甲基化图谱的方法
CN107723363A (zh) * 2016-08-11 2018-02-23 博尔诚（北京）科技有限公司 肿瘤标志物的组合检测方法及其应用
KR20260032575A (ko) 2016-11-30 2026-03-09 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
EP3360971A1 (fr) * 2017-02-09 2018-08-15 Epiontis GmbH Procédé amélioré de comptage de cellules immunitaires épigénétiques
WO2018195217A1 (fr) 2017-04-19 2018-10-25 Singlera Genomics, Inc. Compositions et procédés pour la construction de bibliothèques et l'analyse de séquences
CN109609629A (zh) * 2017-09-30 2019-04-12 博尔诚（北京）科技有限公司 用于检测肝癌的组合物及其用途
AU2019234843B2 (en) 2018-03-13 2025-12-04 Grail, Inc. Anomalous fragment detection and classification
WO2019195268A2 (fr) 2018-04-02 2019-10-10 Grail, Inc. Marqueurs de méthylation et panels de sondes de méthylation ciblés
CN108866191B (zh) * 2018-07-26 2021-07-09 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep2
CN108866192B (zh) * 2018-07-26 2021-06-22 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep1
CA3111887A1 (fr) 2018-09-27 2020-04-02 Grail, Inc. Marqueurs de methylation et panels de sondes de methylation ciblees
EP3899953A1 (fr) 2018-12-21 2021-10-27 Grail, Inc. Source de déconvolution d'origine basée sur des fragments de méthylation dans des échantillons d'adn acellulaire
CN115786517A (zh) * 2019-02-14 2023-03-14 博尔诚（北京）科技有限公司 一种肠癌患癌、癌前筛查组合物及其用途
CN110211633B (zh) * 2019-05-06 2021-08-31 臻和精准医学检验实验室无锡有限公司 Mgmt基因启动子甲基化的检测方法、测序数据的处理方法及处理装置
CN112063712A (zh) * 2019-10-28 2020-12-11 北京康美天鸿生物科技有限公司 基于高分辨率熔解曲线检测septin9基因甲基化的特异引物对和试剂盒
AU2020406068A1 (en) * 2019-12-16 2022-07-14 New Day Diagnostics Llc Methods for detecting colorectal cancer
KR102637032B1 (ko) * 2020-01-28 2024-02-15 주식회사 젠큐릭스 특정 유전자의 CpG 메틸화 변화를 이용한 방광암 진단용 조성물 및 이의 용도
WO2023017001A1 (fr) 2021-08-09 2023-02-16 Epigenomics Ag Méthodes améliorées de détection du cancer colorectal
CN113584032B (zh) * 2021-08-20 2023-08-29 深圳市恩辑生物科技有限公司 一种迷你启动子pAPP及其应用
CN113862349A (zh) * 2021-10-26 2021-12-31 山东师范大学 一种肺纤维化诊断生物标志物
CN114783511B (zh) * 2022-02-25 2025-03-25 深圳市硬核酸生物科技有限公司 核酸分子溶液浓度推荐方法及装置、计算机设备
WO2024074558A1 (fr) 2022-10-04 2024-04-11 Epigenomics Ag Procédés améliorés de détection du cancer
WO2025019568A1 (fr) * 2023-07-17 2025-01-23 The Penn State Research Foundation Amélioration de thérapies à base de cellules immunitaires contre des tumeurs solides avec des protéines de septine optogénétiquement modifiées

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) * 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) * 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
ATE178939T1 (de) 1993-11-30 1999-04-15 Univ Mcgill Dna methyltransferase inhibierung
US5597696A (en) * 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US5871917A (en) 1996-05-31 1999-02-16 North Shore University Hospital Research Corp. Identification of differentially methylated and mutated nucleic acids
US6017704A (en) * 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) * 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
JPH1090169A (ja) 1996-09-19 1998-04-10 Bunshi Bio Photonics Kenkyusho:Kk 顕微鏡装置
CN1232499A (zh) 1996-10-01 1999-10-20 居德伦·拉波尔德－赫尔布兰德 人生长基因和身材矮小基因区
AU7829398A (en) * 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
GB9726539D0 (en) 1997-12-16 1998-02-11 Univ Dundee Polypeptides, polynucleotides and uses thereof
GB9805918D0 (en) * 1998-03-19 1998-05-13 Nycomed Amersham Plc Sequencing by hybridisation
AUPP312998A0 (en) * 1998-04-23 1998-05-14 Commonwealth Scientific And Industrial Research Organisation Diagnostic assay
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) * 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
JP2000221136A (ja) 1999-01-29 2000-08-11 Jasco Corp 経時変化追跡方法および装置
US6331393B1 (en) * 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6783933B1 (en) * 1999-09-15 2004-08-31 The Johns Hopkins University School Of Medicine CACNA1G polynucleotide, polypeptide and methods of use therefor
AU1141301A (en) * 1999-10-19 2001-04-30 Universiteit Gent Identification of bpesc1, a novel gene disrupted by a balanced chromosomal translocation t(3;4)(q23;p15.2) in patient with bpes
JP3783826B2 (ja) 2000-01-17 2006-06-07 横河電機株式会社 バイオチップ読み取り装置
WO2005000087A2 (fr) * 2003-06-03 2005-01-06 Chiron Corporation Produits genetiques exprimes de facon differentielle dans des cellules cancereuses du colon et leurs methodes d'utilisation ii
CA2420840A1 (fr) * 2000-09-01 2003-02-27 Epigenomics Ag Procede de determination du degre de methylation de cytosines determinees d'adn genomique dans le contexte sequentiel 5'-cpg-3'
US6756200B2 (en) * 2001-01-26 2004-06-29 The Johns Hopkins University School Of Medicine Aberrantly methylated genes as markers of breast malignancy
DE10112515B4 (de) 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
US7473767B2 (en) * 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
JP2005515787A (ja) * 2001-10-18 2005-06-02 ラブレイス レスピレイトリー リサーチ インスティチュート 転写因子遺伝子ＰＡＸ５α、ＰＡＸ５β、新規ループヘリックスループタンパク質、新規遺伝子２、およびベータ３遺伝子のプロモーターの異常メチル化による癌のモニタリング
WO2003042661A2 (fr) * 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer
JP3448654B2 (ja) 2001-11-22 2003-09-22 北陸先端科学技術大学院大学長 バイオチップ、バイオチップアレイ、及びそれらを用いたスクリーニング方法
EP1485399A4 (fr) 2001-11-30 2008-01-02 Univ Johns Hopkins Procedes d'analyse des ilots cpg et des regions riches en cg methyles
JP2003232725A (ja) 2002-02-12 2003-08-22 Japan Science & Technology Corp 表面プラズモン共鳴測定法を用いる化学反応解析センサ
DE10228917A1 (de) 2002-06-24 2004-01-22 Epigenomics Ag Vorrichtung zur Handhabung von Flüssigkeiten in einer Mehrzahl von Kanälen
JP4199609B2 (ja) 2002-07-12 2008-12-17 三菱化学株式会社 分析用チップ、分析用チップユニット及び分析装置ならびに分析用チップの作製方法
ES2309336T3 (es) 2002-07-16 2008-12-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Derivados de 4,4-ditiobis-(3-aminobutano-1-sulfanatos) nuevos y composiciones que los contienen.
US20060024684A1 (en) 2002-10-01 2006-02-02 Epigenomics Ag Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
DE10245779A1 (de) 2002-10-01 2004-04-29 Epigenomics Ag Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen
ES2447566T3 (es) 2002-10-01 2014-03-12 Epigenomics Ag Uso de ácidos nucleicos de PITX2 para mejorar el tratamiento de trastornos proliferativos de células mamarias
DE10317955A1 (de) 2003-04-17 2004-11-25 Epigenomics Ag Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen
JP2004156911A (ja) 2002-11-01 2004-06-03 Osaka Industrial Promotion Organization 表面プラズモン蛍光顕微鏡、および表面プラズモンにより励起された蛍光を測定する方法
JP2004212204A (ja) 2002-12-27 2004-07-29 Olympus Corp 蛍光顕微鏡及び蛍光寿命の測定方法、並びに蛍光寿命の測定用プログラム
WO2004074441A2 (fr) * 2003-02-19 2004-09-02 Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services Amplification ou surexpression de la fusion du type septine mll (msf), septine9 et procedes connexes
US20040265833A1 (en) * 2003-06-23 2004-12-30 Cathy Lofton-Day Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
EP1636386B1 (fr) 2003-06-23 2015-08-05 Epigenomics AG Methodes et acides nucleiques pour l'analyse de troubles de la proliferation de cellules colorectales
DE602004021192D1 (de) 2003-10-09 2009-07-02 Epigenomics Ag Verbesserte bisulfitkonversion von dna
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
EP1697497A4 (fr) 2003-11-03 2008-04-23 Gene News Inc Biomarqueurs du cancer du foie
CA2548528A1 (fr) 2003-12-01 2005-06-16 Epigenomics Ag Procedes et acides nucleiques pour l'analyse de l'expression genique associee a la survenue de troubles cellulaires proliferants de la prostate
EP1561821B1 (fr) 2003-12-11 2011-02-16 Epigenomics AG Marqueurs pour le pronostic de la réponse à la thérapie et/ou de la survie chez les patients du cancer du sein
DE602004031405D1 (de) 2003-12-11 2011-03-31 Epigenomics Ag Marker zur Prognose der Reaktion auf Therapie bzw. der Überlebensrate von Brustkrebspatienten
US20080249118A1 (en) 2004-05-17 2008-10-09 Heiko Hermeking Silencing of Tumor-Suppressive Genes by Cpg-Methylation in Prostate Cancer
DE102004029700A1 (de) 2004-06-15 2006-02-09 Epigenomics Ag Verfahren zur Quantifizierung methylierter DNA
WO2005123945A2 (fr) 2004-06-21 2005-12-29 Epigenomics Ag Marqueurs epigenetiques destines au traitement du cancer du sein
EP2302073A1 (fr) * 2004-07-18 2011-03-30 Epigenomics AG Procédés épigénétiques et acides nucléiques pour la détection de troubles cellulaires proliférables du sein
JP4192862B2 (ja) 2004-07-20 2008-12-10 ダイソー株式会社 ポリエーテル系共重合体の製造方法
JP2008521412A (ja) 2004-11-30 2008-06-26 ベリデックス・エルエルシー 肺癌予後判定手段
EP2213749A1 (fr) * 2004-12-02 2010-08-04 Epigenomics AG Procédés et acides nucléiques pour l'analyse de l'expression génétique associée au pronostic de troubles prolifératifs de cellules prostatiques
EP1877577A2 (fr) * 2005-04-15 2008-01-16 Epigenomics Inc. Méhodes et acides nucléiques utilisés dans des analyses de troubles prolifératifs cellulaires
US20090005268A1 (en) 2005-07-18 2009-01-01 Epigenomics Ag Compositions and Methods for Cancer Diagnostics Comprising Pan-Cancer Markers
WO2007115213A2 (fr) 2006-03-30 2007-10-11 Epigenomics Ag Méthodes et acides nucléiques pour des analyses de troubles prolifératifs cellulaires
EP2013360A2 (fr) 2006-04-17 2009-01-14 Epigenomics AG Procédés et acides nucléiques pour détecter des troubles de prolifération de cellules colorectales

Also Published As

Publication number Publication date
KR20130021400A (ko) 2013-03-05
US20060286576A1 (en) 2006-12-21
WO2006113466A8 (fr) 2012-04-12
JP5808306B2 (ja) 2015-11-10
EA200702203A1 (ru) 2008-04-28
IL186556A0 (en) 2008-01-20
US8900829B2 (en) 2014-12-02
SG183708A1 (en) 2012-09-27
CN107663538A (zh) 2018-02-06
CN107663538B (zh) 2022-03-18
IL186556A (en) 2014-05-28
CA2606296A1 (fr) 2006-10-26
BRPI0607508A2 (pt) 2009-09-15
US7749702B2 (en) 2010-07-06
US7951563B2 (en) 2011-05-31
AU2006236620A1 (en) 2006-10-26
EA013634B1 (ru) 2010-06-30
US20150086989A1 (en) 2015-03-26
SI1721992T1 (sl) 2009-04-30
US10385402B2 (en) 2019-08-20
AU2006236620B2 (en) 2012-02-23
US20090075260A1 (en) 2009-03-19
HK1250521A1 (zh) 2018-12-21
US20220154287A1 (en) 2022-05-19
WO2006113466A2 (fr) 2006-10-26
CN114921544A (zh) 2022-08-19
ATE410524T1 (de) 2008-10-15
JP2008538497A (ja) 2008-10-30
CN104046686B (zh) 2017-07-28
PL1721992T3 (pl) 2009-04-30
EP1721992B1 (fr) 2008-10-08
EP1721992A2 (fr) 2006-11-15
US9695478B2 (en) 2017-07-04
PT1721992E (pt) 2009-01-14
EP2009115A2 (fr) 2008-12-31
US20110039719A1 (en) 2011-02-17
ES2533767T3 (es) 2015-04-15
BRPI0607508B8 (pt) 2021-07-27
US20110244458A1 (en) 2011-10-06
MX2007012782A (es) 2008-03-14
US11186879B2 (en) 2021-11-30
JP5341506B2 (ja) 2013-11-13
US20160304964A1 (en) 2016-10-20
CA2606296C (fr) 2019-05-21
KR101708544B1 (ko) 2017-02-20
KR20080011287A (ko) 2008-02-01
EP2009115A3 (fr) 2009-02-25
EP1877577A2 (fr) 2008-01-16
BRPI0607508B1 (pt) 2021-01-12
HK1202137A1 (en) 2015-09-18
DE602006003012D1 (de) 2008-11-20
ES2315956T3 (es) 2009-04-01
EP2045335A1 (fr) 2009-04-08
US20190316210A1 (en) 2019-10-17
WO2006113466A3 (fr) 2007-01-18
EP1721992A3 (fr) 2006-12-20
EP2045335B1 (fr) 2014-12-31
JP2013090629A (ja) 2013-05-16
CN104046686A (zh) 2014-09-17
KR20150006089A (ko) 2015-01-15

Similar Documents

Publication Publication Date Title
DK1721992T3 (da) Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme
DK2258871T3 (da) Fremgangsmåder og nukleinsyrer til analyse af celleproliferative lidelser
WO2007118704A3 (fr) Procédés et acides nucléiques pour détecter des troubles de prolifération de cellules colorectales
EP2195449A4 (fr) Méthodes et trousses utiles pour amplifier, détecter ou quantifier sélectivement de l'adn cible ayant des séquences terminales spécifiques
DE602005009702D1 (de) Esr1 und gebärmutterhalskrebs
DK1871912T3 (da) Fremgangsmåde til bestemmelse af DNA-methylering i blod- eller urinprøver
WO2009074328A8 (fr) Methodes et acides nucleiques permettant d'analyser les troubles de la proliferation cellulaire
WO2005001141A3 (fr) Methodes et acides nucleiques pour l'analyse de troubles de la proliferation de cellules colorectales
BRPI0816047A2 (pt) conjunto de oligonucleotídeos para detecção de um ácido nucleico alvo, métodos para detecção da presença ou ausência de um ácido nucleico alvo e de pelo menos dois ácidos nucleicos alvo, kit, mistura de reação e amplicon identificado por fluorescência
WO2008011620A3 (fr) Procédés et acides nucléiques destinés aux analyses de troubles associés à une prolifération cellulaire
WO2008008983A3 (fr) Procédés et acides nucléiques pour des analyses de problèmes de la prolifération cellulaire
WO2010007083A3 (fr) Procédés et acides nucléiques pour l’analyse de troubles prolifératifs cellulaires
WO2006034879A3 (fr) Techniques epigenetiques et acides nucleiques de detection de troubles proliferatifs des cellules pulmonaires
WO2007115213A3 (fr) Méthodes et acides nucléiques pour des analyses de troubles prolifératifs cellulaires
WO2009065511A3 (fr) Procédés et acides nucléiques pour l'analyse de l'expression génique associée au développement de troubles prolifératifs de cellules de la prostate
WO2005001140A3 (fr) Methodes et acides nucleiques destines a analyser des troubles a evolution chronique des cellules du colon
DE602005020592D1 (de) Cpg-amplicon und array-protokoll
WO2004096021A3 (fr) Analyse globale d'elements transposables en tant que marqueurs moleculaires du cancer
EP1954837A4 (fr) Bio-essai de pcr cinétique permettant de quantifier l'amplification génique sur le chromosome 17